Argent Biopharma Limited has released a press release.
Pre-clinical Trial Results on CimetrA
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- MGC Pharma Launches Share Purchase Plan
- MGC receives permission for first import of Psilocybin
- Commitments Received for GBP 0.7m
- AMC Places Second Order of ArtemiC for US$1M
- Malta Production Facility Receives EU-GMP Approval
Later from Argent Biopharma
- Share Purchase Plan Closed
- Pause in trading
- Retraction of Statement
- Company Update & Capital Raising
- Placing to Raise US$500,000
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma